StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
10
Publishing Date
2023 - 10 - 24
10
2023 - 10 - 04
8
2023 - 05 - 19
9
2023 - 05 - 02
13
2022 - 06 - 13
12
2022 - 05 - 19
9
2022 - 05 - 03
9
2022 - 04 - 25
9
2022 - 03 - 01
11
2022 - 02 - 17
8
2022 - 02 - 15
9
2022 - 01 - 06
8
2022 - 01 - 04
9
2021 - 12 - 20
9
2021 - 12 - 14
8
2021 - 12 - 13
12
2021 - 12 - 09
10
2021 - 12 - 01
8
2021 - 11 - 12
21
2021 - 11 - 11
8
2021 - 11 - 09
12
2021 - 11 - 08
8
2021 - 11 - 04
9
2021 - 11 - 02
10
2021 - 10 - 22
9
2021 - 10 - 21
12
2021 - 10 - 20
12
2021 - 10 - 14
8
2021 - 10 - 12
10
2021 - 10 - 04
13
2021 - 10 - 01
24
2021 - 09 - 15
8
2021 - 09 - 09
8
2021 - 07 - 19
8
2021 - 06 - 23
8
2021 - 06 - 17
8
2021 - 06 - 10
13
2021 - 06 - 07
8
2021 - 06 - 04
11
2021 - 06 - 03
9
2021 - 05 - 12
9
2021 - 05 - 11
8
2021 - 05 - 10
8
2021 - 05 - 04
7
2021 - 04 - 28
8
2021 - 04 - 27
14
2021 - 04 - 26
8
2021 - 04 - 23
7
2021 - 04 - 20
7
2021 - 04 - 19
7
2021 - 04 - 13
9
2021 - 04 - 12
9
2021 - 03 - 29
7
2021 - 03 - 23
7
2021 - 03 - 15
7
2021 - 03 - 08
7
2021 - 01 - 19
13
2021 - 01 - 04
7
2020 - 12 - 21
7
2020 - 12 - 08
8
Sector
Health technology
10
Tags
Acquisition
10
Air
7
Alliances
5
Application
8
Awards
7
Biopharma
8
Biotech
4
Brands
4
Breast cancer
8
Cancer
16
Clinical-trials-phase-iii
4
Collaboration
6
Conference
8
Contract
4
Covid
7
Covid-19
6
Designation
4
Device
5
Diagnostic
5
Disease
5
Distribution
4
Drug
7
Ema
11
Energy
15
Europe
4
Events
4
Expansion
5
Fda
11
Financial results
11
Food
4
Genetic
5
Granted
4
Growth
19
Health
12
Iot
9
Lithium
4
Liver
7
Media
5
Merge
4
N/a
362
Offering
12
Order
7
Partnership
6
People
7
Phase 1
6
Phase 3
6
Positive
16
Potential
6
Presentation
5
Research
11
Results
39
Symposium
7
T-cell
6
Technology
9
Test
12
Therapeutics
21
Therapy
10
Treatment
12
Trial
22
Vaccine
6
Entities
Atara biotherapeutics, inc.
1
Avalon globocare corp.
1
Compugen ltd.
1
Cytokinetics, incorporated
2
Ocugen, inc.
1
Oncocyte corporation
1
Sorrento therapeutics, inc.
1
Sqz biotechnologies company
1
Uniqure n.v.
1
Symbols
ATRA
1
AVCO
1
CGEN
1
CYTK
2
OCGN
1
OCX
1
QURE
1
SQZ
1
SRNE
1
Exchanges
Amex
1
Nasdaq
8
Nyse
1
Crawled Date
2021 - 12 - 10
1
2021 - 12 - 09
9
Crawled Time
00:00
1
12:30
3
13:00
2
14:00
1
17:00
2
20:00
1
Source
www.biospace.com
3
www.globenewswire.com
6
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2021 - 12 - 09
tags :
Therapy
save search
Spotlight Poster Presentation at San Antonio Breast Cancer Symposium SABCS 2021 Shows Oncocyte’s DetermaIO™ Clinical Test Predicts Response to Immunotherapy in Triple Negative Breast Cancer
Published:
2021-12-09
(Crawled : 00:00)
- globenewswire.com
OCX
J
|
$2.52
-2.7%
-2.78%
37K
|
Health Technology
|
-3.0%
|
O:
-0.37%
H:
0.0%
C:
0.0%
symposium
sabcs
presentation
immunotherapy
test
therapy
cancer
negative
breast cancer
SQZ Biotechnologies Announces Lead Cell Therapy Candidate Induced Radiographic, Symptomatic and Immune Response as Monotherapy in Post-Checkpoint HPV+ Solid Tumor Patient
Published:
2021-12-09
(Crawled : 20:00)
- biospace.com/
SQZ
|
$0.435
0.0%
30M
|
Health Technology
|
-96.29%
|
O:
-1.88%
H:
4.08%
C:
1.22%
hpv
therapy
biotech
iot
Avalon GloboCare Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development
Published:
2021-12-09
(Crawled : 17:00)
- globenewswire.com
AVCO
|
$0.45
-16.15%
31.11%
|
Health Technology
|
-51.61%
|
O:
-3.14%
H:
3.24%
C:
-1.2%
technology
therapy
designation
Scilex Holding Company, a Sorrento Therapeutics, Inc. Subsidiary, Announces Highly Significant Positive Top-Line Results from its Phase 3 Non-Opioid Injectable SP-102 (SEMDEXA™) Pivotal Trial C.L.E.A.R. Program for Sciatica Pain Management Supporting the Potential Use of SP-102 as a Best-in-Class Therapy
Published:
2021-12-09
(Crawled : 17:00)
- globenewswire.com
SRNE
|
$0.028
-8.85%
42K
|
Health Technology
|
-99.52%
|
O:
1.03%
H:
2.75%
C:
-2.6%
sp-102
trial
therapeutics
potential
opioid
positive
therapy
results
phase 3
topline
Atara Biotherapeutics Announces Preliminary Results for ATA2271, a Next-Generation Autologous Mesothelin-targeted CAR T-cell Therapy for Solid Tumors, at ESMO Immuno-Oncology Congress 2021
Published:
2021-12-09
(Crawled : 14:00)
- biospace.com/
ATRA
|
$0.6917
-3.25%
-3.35%
830K
|
Health Technology
|
-96.17%
|
O:
-2.59%
H:
1.04%
C:
-5.89%
ata2271
solid tumors
therapeutics
therapy
results
iot
t-cell
Cytokinetics Announces Receipt of Breakthrough Therapy Designation from FDA for Aficamten
Published:
2021-12-09
(Crawled : 13:00)
- globenewswire.com
CYTK
|
$67.0
-1.37%
-1.39%
890K
|
Health Technology
|
81.87%
|
O:
-2.93%
H:
0.0%
C:
0.0%
fda
therapy
breakthrough therapy
designation
Cytokinetics Announces Receipt of Breakthrough Therapy Designation from FDA for AficamtenFDA Granted Designation for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy Based on Results of REDWOOD-HCM
Published:
2021-12-09
(Crawled : 13:00)
- biospace.com/
CYTK
|
$67.0
-1.37%
-1.39%
890K
|
Health Technology
|
81.87%
|
O:
-2.93%
H:
0.0%
C:
0.0%
treatment
fda
cardio
granted
therapy
results
breakthrough therapy
designation
Compugen Presents Preliminary Translational Data Demonstrating Immune Activation in the Tumor Microenvironment by COM701 at the TIGIT Therapies Digital Summit
Published:
2021-12-09
(Crawled : 12:30)
- prnewswire.com
CGEN
|
$2.03
3.57%
3.45%
450K
|
Health Technology
|
-47.24%
|
O:
6.91%
H:
2.16%
C:
0.86%
com701
therapy
uniQure and CSL Behring Announce Primary Endpoint Achieved in HOPE-B Pivotal Trial of Etranacogene Dezaparvovec Gene Therapy in Patients with Hemophilia B
Published:
2021-12-09
(Crawled : 12:30)
- globenewswire.com
QURE
|
$4.71
0.86%
0.85%
440K
|
Health Technology
|
-83.63%
|
O:
5.19%
H:
1.33%
C:
-6.6%
gene therapy
trial
therapy
Ocugen, Inc. Announces U.S. FDA Acceptance of Investigational New Drug Application to Initiate a Phase 1/2 Clinical Trial for Gene Therapy Candidate OCU400 to Treat Inherited Retinal Degeneration
Published:
2021-12-09
(Crawled : 12:30)
- globenewswire.com
OCGN
|
News
A
|
$1.315
-8.68%
-9.51%
8M
|
Health Technology
|
-74.13%
|
O:
7.46%
H:
0.31%
C:
-12.81%
ocu400
new drug
fda
application
gene therapy
drug
trial
fda acceptance
phase 1
therapy
retina
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.